Effect of soy isoflavones on C-reactive protein in chronic inflammatory disorders
A systematic review and meta-analysis
Abstract
Abstract: New evidence suggests that soy products might reduce chronic systemic inflammation. Therefore, we aimed to summarize the effect of soy isoflavones on serum concentration of C-reactive protein (CRP) among participants with chronic inflammatory disorders by conducting this study. Cochrane Library, Scopus, ISI Web of Science, clinicaltrials.gov, and PubMed were searched to identify randomized clinical trials (RCTs) published up to December 2020. The effect size was calculated by the mean change from baseline in concentrations of CRP and its standard deviation for both intervention and comparison groups. DerSimonian and Laird random-effects model was used when the heterogeneity test was statistically significant. In total, thirteen RCTs involving 1213 participants and ten RCTs involving 1052 participants were eligible for our systematic review and meta-analysis respectively. Study duration ranged from 4 to 96 weeks and soy isoflavones dose varied from 33 to 132 mg/day. Overall effect size indicated a non-significant effect on serum concentration of CRP following soy isoflavones intake (weighted mean differences (WMD)=−0.15 mg/L, 95% confidence interval (CI): −0.54, 0.23; p=0.430). Subgroup analysis revealed that soy isoflavones significantly reduced serum concentration of CRP in studies among participants with age >57 years and baseline CRP levels >3.75 mg/L. The present study proposed that soy isoflavones could not significantly reduce serum CRP levels. It seems more RCTs on participants with age more than 57 years and higher levels of CRP is necessary.
References
1 . Inflammation and metabolic disorders. Nature. 2006;444(7121):860–7.
2 . Linking the inflammasome to obesity-related disease. Nat Med. 2011;17(2):164–5.
3 Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. J Clin Endocrinol Metab. 2005;90(3):1734–40.
4 . C Reactive Protein. 2021 Dec 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
5 . Biomarker für chronisch-entzündliche Erkrankungen
[Biomarkers for chronic inflammatory diseases] . Z Rheumatol. 2015;74(10):887–96.6 Anti-inflammatory treatments for chronic diseases: a review. Inflamm Allergy Drug Targets. 2013;12(5):349–61.
7 . Can resveratrol supplement change inflammatory mediators? A systematic review and meta-analysis on randomized clinical trials. Eur J Clin Nutr. 2019;73(3):345–55.
8 . The effect of alpha-lipoic acid on inflammatory mediators: a systematic review and meta-analysis on randomized clinical trials. Eur J Pharmacol. 2019;849:115–23.
9 Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr. 2003;133(9):2874–8.
10 . Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation. 2007;116(22):2553–62.
11 Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88(1):38–50.
12 . Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr. 2007;85(4):1148–56.
13 . Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans. J Nutr. 2004;134(9):2395–400.
14 . Genistein as an anti-inflammatory agent. Inflamm Res. 2003;52(8):341–6.
15 Activation of glutathione peroxidase via Nrf1 mediates genistein’s protection against oxidative endothelial cell injury. Biochem Biophys Res Commun. 2006;346(3):851–9.
16 . Soy consumption, adhesion molecules, and pro-inflammatory cytokines: a brief review of the literature. Nutr Rev. 2009;67(4):213–21.
17 . Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr. 1998;68(6 Suppl):1333s–46s.
18 . Isoflavones: anti-inflammatory benefit and possible caveats. Nutrients. 2016;8(6):361.
19 . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
20 Higgins JPTThomas JChandler JCumpston MLi TPage MJWelch VA (editors) Cochrane handbook for systematic reviews of interventions. (2nd edition). Chichester (UK): John Wiley & Sons; 2019.
21 . Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13.
22 . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
23 . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
24 . Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study. Menopause. 2007;14(4):624–9.
25 Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke. Eur Heart J. 2008;29(22):2800–7.
26 . Effects of isoflavone dietary supplementation on cardiovascular risk factors in type 2 diabetes. Diabetes Care. 2007;30(7):1871–3.
27 . Soybean isoflavones ameliorate ischemic cardiomyopathy by activating Nrf2-mediated antioxidant responses. Food Funct. 2017;8(8):2935–44.
28 Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women. Mol Nutr Food Res. 2014;58(4):709–17.
29 . The effects of isoflavones combined with soy protein on lipid profiles, C-reactive protein and cardiovascular risk among postmenopausal Chinese women. Nutr Metab Cardiovasc Dis. 2012;22(9):712–9.
30 Soy isoflavones, diet and physical exercise modify serum cytokines in healthy obese postmenopausal women. Phytomedicine. 2011;18(4):245–50.
31 . Soy isoflavones improve insulin sensitivity without changing serum leptin among postmenopausal women. Climacteric. 2012;15(6):611–20.
32 . Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women. J Clin Endocrinol Metab. 2003;88(11):5180–5.
33 . Effect of exercise training combined with phytoestrogens on adipokines and C-reactive protein in postmenopausal women: a randomized trial. Metabolism. 2012;61(2):273–80.
34 Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr. 2007;137(10):2270–8.
35 . The Effects of Soy Isoflavones on Metabolic Status of Patients With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2016;101(9):3386–94.
36 . Additive effects of isoflavones and exercise training on inflammatory cytokines and body composition in overweight and obese postmenopausal women: a randomized controlled trial. Menopause. 2014;21(8):869–75.
37 . Biological effect of soy isoflavones in the prevention of civilization diseases. Nutrients. 2019;11(7):1660.
38 . Soy and health update: evaluation of the clinical and epidemiologic literature. Nutrients. 2016;8(12):754.
39 . Current perspectives on the beneficial effects of soybean isoflavones and their metabolites for humans. Antioxidants (Basel). 2021;10(7):1064.
40 . Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3. Immunology. 2003;108(4):539–47.
41 . NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.
42 Daidzein administration in vivo reduces myocardial injury in a rat ischemia/reperfusion model by inhibiting NF-kappaB activation. Life Sci. 2009;84(7–8):227–34.
43 . Equol: history, chemistry, and formation. J Nutr. 2010;140(7):1355s–62s.
44 Equol production changes over time in postmenopausal women. J Nutr Biochem. 2012;23(6):573–9.
45 . Estrogen accelerates the resolution of inflammation in macrophagic cells. Sci Rep. 2015;5:15224.
